Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report

Authors

  • Muhammad Khifzhon Azwar Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Fauzia Kirana Permata Jonggol Hospital, Bogor, Indonesia
  • Adi Kurniawan Permata Jonggol Hospital, Bogor, Indonesia
  • Sri Handayani Permata Jonggol Hospital, Bogor, Indonesia
  • Siti Setiati Department of Internal Medicine – Clinical Epidemiology and Evidence-Based Medicine, Cipto Mangunkusumo Hospital – Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

Keywords:

COVID-19, SARS-CoV-2, Abdominal Pain, Gastrointestinal Symptom, Indonesia

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a widespread infection in the world. During the pandemic, physicians may need to raise the index of suspicion earlier in at-risk patients presenting with gastrointestinal symptoms, which are uncommon findings in coronavirus disease 2019 (COVID-19) patients. We report a patient in Indonesia with chest pain and gastrointestinal symptoms who was later confirmed to have SARS-CoV-2 infection after spending days of hospitalisation in the standard ward.

References

Wong SH, Lui RNS, Sung JJY. Covid‐19 and the Digestive System. J Gastroenterol Hepatol [serial on the internet]. 2020 Mar 25 [cited 2020 Apr 5]; [about 13 p.]. Available from: https://doi.org/10.1111/jgh.15047.

Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol [serial on the internet]. 2020 [cited 2020 Apr 5]; [about 25 p.]. Available from: https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf

Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020 Mar 12. pii: ciaa248. doi: 10.1093/cid/ciaa248.

Panahi L, Amiri M, Pouy S. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med. 2020; 8(1): e34.

Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission. Gastroenterology. 2020 Mar 3. pii: S0016-5085(20)30281-X. doi: 10.1053/j.gastro.2020.02.054.

Song Y, Liu P, Shi XL, et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020 Mar 5. pii: gutjnl-2020-320891. doi: 10.1136/gutjnl-2020-320891.

Occupational Saftey and Health Administration. Worker Exposure Risk to COVID-19. USA: Occupational Saftey and Health Administration; 2020 [cited 2020 Apr 5]. Available from: https://www.osha.gov/Publications/OSHA3993.pdf

Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 Mar 10. doi: 10.7326/M20-0504.

Grossi L, Ciccaglione AF, Marzio L. Esophagitis and its causes: Who is “guilty” when acid is found “not guilty”?. World J Gastroenterol. 2017 May 7; 23(17): 3011–3016. doi: 10.3748/wjg.v23.i17.3011.

Yan G, Lee CK, Lam LTM, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30158-4. doi: 10.1016/S1473-3099(20)30158-4.

Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology [serial on the internet]. 2020 [cited 2020 Apr 5]; [about 28p.]. Available from: https://doi.org/10.1148/radiol.2020200823.

Salehi S, Abedi A, Balakrishnan S, et al. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. American Journal of Roentgenology. 2020; 215: 1-7. doi: 10.2214/AJR.20.23034

Susilo A, Rumende CM, Pitoyo CW, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia. 2020 Mar; 7(1): 45-77.

Mehta P, McAuley DF, Brown M, et al. Lancet [serial on the internet]. 2020 [cited 2020 Apr 5]; [about 2 p.]. Available from: https://doi.org/10.1016/S0140-6736(20)30628-0.

Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. 2015 Jun; 38(3): 93–94. doi: 10.18773/austprescr.2015.034.

Lippi G, Plebani M. Laboratory abnoralities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 Mar 3. pii: /j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml. doi: 10.1515/cclm-2020-0198.

Rong X, Yang L, Chu H, et al. Effect of delay in diagnosis on transmission of COVID-19. Mathematical Biosciences and Engineering. 2020; 17(3): 2725-2740. doi: 10.3934/mbe.2020149.

Downloads

Published

2020-04-14

How to Cite

Azwar, M. K., Kirana, F., Kurniawan, A., Handayani, S., & Setiati, S. (2020). Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report. Acta Medica Indonesiana, 52(1), 63. Retrieved from https://www.actamedindones.org/index.php/ijim/article/view/1428

Issue

Vol. 52 No. 1 (2020): Acta Medica Indonesiana

Section

CASE REPORT

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.